222 related articles for article (PubMed ID: 26779976)
21. The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women.
Helfgott R; Mittlböck M; Miesbauer M; Moinfar F; Haim S; Mascherbauer M; Schlagnitweit P; Heck D; Knauer M; Fitzal F
Eur J Surg Oncol; 2019 Apr; 45(4):538-543. PubMed ID: 30366878
[TBL] [Abstract][Full Text] [Related]
22. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
[TBL] [Abstract][Full Text] [Related]
23. Value of Breast MRI and Nomogram After Negative Axillary Ultrasound for Predicting Axillary Lymph Node Metastasis in Patients With Clinically T1-2 N0 Breast Cancer.
Song SE; Cho KR; Cho Y; Jung SP; Park KH; Woo OH; Seo BK
J Korean Med Sci; 2023 Aug; 38(34):e251. PubMed ID: 37644678
[TBL] [Abstract][Full Text] [Related]
24. Comparison between Ultrasound and Pathologic Status of Axillary Lymph Nodes in Clinically Node-negative Breast Cancer Patients.
Bailey A; Layne G; Shahan C; Zhang J; Wen S; Radis S; Richmond B; Partin J; Hazard H
Am Surg; 2015 Sep; 81(9):865-9. PubMed ID: 26350662
[TBL] [Abstract][Full Text] [Related]
25. The impact of preoperative axillary ultrasonography in T1 breast tumours.
del Riego J; Diaz-Ruiz MJ; Teixidó M; Ribé J; Vilagran M; Canales L; Sentís M;
Eur Radiol; 2016 Apr; 26(4):1073-81. PubMed ID: 26162580
[TBL] [Abstract][Full Text] [Related]
26. The SAVE review: sonographic analysis versus excision for axillary staging in breast cancer.
Henry-Tillman R; Glover-Collins K; Preston M; Gallagher K; Tummel E; Robertson YV; Ochoa D; Korourian S; Westbrook K; Klimberg VS
J Am Coll Surg; 2015 Apr; 220(4):560-7. PubMed ID: 25797740
[TBL] [Abstract][Full Text] [Related]
27. Initial axillary staging of breast cancer using ultrasound-guided fine needle aspiration: a liquid-based cytology study.
Schiettecatte A; Bourgain C; Breucq C; Buls N; De Wilde V; de Mey J
Cytopathology; 2011 Feb; 22(1):30-5. PubMed ID: 20337693
[TBL] [Abstract][Full Text] [Related]
28. Does use of axillary ultrasound in clinically node-negative patients receiving neo-adjuvant systemic therapy for breast cancer lead to surgical overtreatment?
Horwood C; Ma N; Hayek J; Terando AM; Agnese DM; Grignol V
Breast J; 2020 Feb; 26(2):120-124. PubMed ID: 31435992
[TBL] [Abstract][Full Text] [Related]
29. The predictive value of sentinel node biopsy in early breast cancer after neo-adjuvant chemotherapy: A prospective study.
Najim O; Dockx Y; Huyghe I; van den Wyngaert T; Papadimitriou K; Tjalma WAA; Huizing MT
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():108-111. PubMed ID: 30145524
[TBL] [Abstract][Full Text] [Related]
30. Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011.
Boland MR; Prichard RS; Daskalova I; Lowery AJ; Evoy D; Geraghty J; Rothwell J; Quinn CM; O'Doherty A; McDermott EW
Eur J Surg Oncol; 2015 Apr; 41(4):559-65. PubMed ID: 25648466
[TBL] [Abstract][Full Text] [Related]
31. Population-based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node-positive invasive lobular carcinoma of the breast.
Morrow E; Lannigan A; Doughty J; Litherland J; Mansell J; Stallard S; Mallon E; Romics L
Br J Surg; 2018 Jul; 105(8):987-995. PubMed ID: 29623677
[TBL] [Abstract][Full Text] [Related]
32. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration.
Yu Y; Cui N; Li HY; Wu YM; Xu L; Fang M; Sheng Y
BMC Cancer; 2016 Oct; 16(1):808. PubMed ID: 27756234
[TBL] [Abstract][Full Text] [Related]
34. Surgical Staging of the Axilla: Is It on Its Way Out? A Retrospective Study and Review of the Literature.
Chowdhury D; Drehuta I; Bhattacharya S
Clin Breast Cancer; 2017 Nov; 17(7):578-580. PubMed ID: 28600146
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Accuracy of Axillary Ultrasonography Compared with Intra-operative Pathological Findings in Patients with Breast Cancer.
Rezvani A; Zahergivar A; Iranpour P; Akrami M; Kazemi S
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3615-3621. PubMed ID: 30583690
[TBL] [Abstract][Full Text] [Related]
36. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
37. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
38. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
[TBL] [Abstract][Full Text] [Related]
39. Predictors of false negative axillary ultrasound in breast cancer.
Nwaogu IY; Yan Y; Appleton CM; Cyr AE; Margenthaler JA
J Surg Res; 2015 Oct; 198(2):351-4. PubMed ID: 25891674
[TBL] [Abstract][Full Text] [Related]
40. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
